Background Malaria remains a significant health problem in Yemen with Plasmodium
falciparum being the predominant species which is responsible for 90% of the malaria …

Background Despite evident success of malaria control in many sites in the Arabian
Peninsula, malaria remains endemic in a few spots, in Yemen and south-west of Saudi …

Chloroquine (CQ) has been the mainstay of treatment of malaria for decades. This cost‐
effective and safe drug has become ineffective for treatment of falciparum malaria in many …

Abstract Background In Yemen, artesunate plus sulfadoxine-pyrimethamine (AS+ SP) has
been used as first-line treatment for uncomplicated falciparum malaria, which accounts for …

Malaria is still a major public health problem in Yemen. More than 95% of the malaria cases
are due to Plasmodium‎ falciparum‎. Recently in Yemen, the antimalarial treatment policy was …

Abstract Background In the Arabian Peninsula malaria control is progressing steadily,
backed by adequate logistic and political support. As a result, transmission has been …

Introduction. Despite the efforts of the malaria control programme, malaria morbidity is still a
common health problem in Yemen, with 60% of the population at risk. Plasmodium …

Malaria still represents a major health problem in Yemen, particularly in Hodeidah, despite
continuing efforts to eliminate it. With the absence of clinically proven vaccines …

Malaria chemotherapy is under constant threat from the emergence and spread of multidrug
resistance of Plasmodium falciparum. Resistance has been observed to almost all currently …

Given that the evolution and spread of resistance to sulfadoxine–pyrimethamine (SP) have
been documented at a quick pace worldwide, the present study investigated the mutant …